Methotrexate in the Treatment of Axial Spondyloarthritis
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The goal of this study is to evaluate the efficacy of oral methotrexate for the treatment of
active axial spondyloarthritis (early ankylosing spondylitis or spondyloarthritis with
sacroiliitis). Efficacy will be measured by reduction in the signs and symptoms of active
spondyloarthritis including effects on back pain and stiffness, range of motion in the spine,
physical function, quality of life and incidence of arthritis, enthesitis and anterior
uveitis.